Skip to main content
    T

    Tempest Therapeutics Inc (TPST)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.33
    -0.01 (-4.24%)

    Market Cap: $7.64M

    Last updated: Nov 17, 2026 at 4:34 PM ET

    Tempest Therapeutics Inc (TPST) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Tempest Therapeutics (TPST) has a market cap of $7.64M and an enterprise value of $12.66M. Its share count is up 280.85% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 65.80% above the market cap, as debt exceeds cash.

    Market Cap$7.64M
    Enterprise Value$12.66M
    Latest price (Nov 17, 2026)$0.33

    Key Dates

    The next earnings report is expected on Mar 29, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 29, 2027 (expected)
    Last Earnings DateNov 13, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 11.08% in the quarter ended Sep 30, 2026 and grew 191.86% a year over 2 years.

    Shares Outstanding16.91M
    Shares Change (YoY)+280.85%
    Shares Change (QoQ)+11.08%
    Share Count Growth (2Y CAGR)+191.86%

    Price Statistics

    The stock is down 96.39% over 52 weeks and trades 50.00% below its 50-day average.

    Beta (1Y)1.04
    52-Week Change-96.39%
    1-Month Change-45.46%
    3-Month Change-69.41%
    6-Month Change-81.61%
    5-Year Change-99.67%
    10-Year Change-100.00%
    Total Return (1Y)-96.39%
    Total Return (3Y CAGR)-80.61%
    Total Return (5Y CAGR)-70.28%
    Max Drawdown (1Y)-96.51%
    Max Drawdown (3Y)-99.54%
    Sharpe Ratio (1Y)-2.57
    Correlation with SPY (1Y)0.11
    50-Day Average$0.66
    200-Day Average$1.36
    52-Week Range$0.34 to $9.25
    RSI (14 Days)23.5
    Average Volume (20 Days)224.37K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.34x current liabilities.

    Current Ratio0.34x
    Quick Ratio0.34x

    Returns and Efficiency

    Return on invested capital is -783.63% over the last 12 months.

    Return on Assets (ROA)-463.30%
    Return on Invested Capital (ROIC)-783.63%
    Return on Capital Employed (ROCE)-991.94%
    ROA (5Y Average)-85.85%

    Scores

    TPST has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Gross Profit-$65.00K
    Operating Income-$39.87M
    Pretax Income-$40.59M
    Net Income-$40.59M
    EBIT-$40.59M
    Reported EPS (TTM)-$1.67

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$897.00K
    Total Debt$5.92M
    Net Debt$5.03M
    Net Debt Per Share$0.30
    Working Capital-$3.06M
    Shareholder Equity-$1.83M
    Total Assets$8.76M
    Total Liabilities$10.59M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$16.00M
    FCF Per Share-$0.80
    Depreciation and Amortization$241.00K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Growth

    Book Value Per Share Growth (2Y CAGR)+13.66%
    Tangible Book Per Share Growth (2Y CAGR)+13.66%

    Revenue and profit by year

    Dividends and Yields

    TPST does not pay a dividend.

    Buyback Yield-169.59%
    Shareholder Yield-169.59%

    Stock Splits

    The last split was a 1-for-13 reverse split on Apr 9, 2025.

    Last Split DateApr 9, 2025
    Split TypeReverse split
    Split Ratio1:13

    Peer Position

    Against 3 similar companies, TPST has the lowest ROIC.

    ROIC-783.63% vs -72.27% median
    Revenue Growth (Trailing 4 Quarters, YoY)-100.00% vs -99.32% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About TPST

    What is TPST's market cap?

    Tempest Therapeutics has a market cap of $7.64M. Its enterprise value, which adds debt and subtracts cash, is $12.66M.

    How many shares of TPST are outstanding?

    Tempest Therapeutics has 16.91M shares outstanding. The count is up 280.85% from a year earlier.

    Does TPST pay a dividend?

    No. Tempest Therapeutics does not pay a dividend.

    How much debt does TPST have?

    Tempest Therapeutics has $5.92M of total debt and $897.00K of cash and equivalents, a net debt position of $5.03M.